Phase 1 N=17 Randomized Treatment

Repetitive Transcranial Magnetic Stimulation for the Treatment of Focal Hand Dystonia

Dystonia, Focal, Task-specific

Bottom Line

View on ClinicalTrials.gov: NCT01884064 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Nov 2015

Primary outcome: Primary: Cortical Silent Period — 9; 1.61 milliseconds

Study Design & Population

Study type: Interventional
Phase: Phase 1
Interventions: rTMS (Device); Sham rTMS (Device)
Age: Adult, Older Adult · 21+ yrs
Sex: All
Sponsor: University of Minnesota
Primary completion: Jul 2010

Outcome Measures

Outcome	Result	p-value
PRIMARY Cortical Silent Period	9; 1.61	—

Summary

This study investigated the short term effects of repeated administrations of repetitive-transcranial magnetic stimulation (rTMS) on clinical changes and investigate neurophysiologic responses to rTMS of the activated motor system in patients with FHD.

Eligibility Criteria

Inclusion Criteria

Task specific Focal Hand Dystonia

Exclusion Criteria

any neurologic condition other than FHD
medication for dystonia
botulinum toxin within the past three months
seizure history
pregnancy
implanted medical devices

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01884064). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.